Biotech Financing Options and Their Implications

In this session recorded at CMO Summit 2022, the panel discusses:

• What CMOs need to know about series funding, crossover and IPO
• How to think about when to engage in these financing options based on the company stage, milestones, and budget
• How CMOs can best support the decision-making and fundraising processes

Speakers:

• Nerissa Kreher, MD, MBA, CMO, Entrada Therapeutics
• Geoff Meyerson, MBA, Co-Founder & CEO, Locust Walk
• Tariq Kassum, MD, CEO, Celsius Therapeutics
• Ann Barbier, MD, PhD, CMO, CAMP4 Therapeutics